These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28707490)

  • 1. Transferon™, a peptide mixture with immunomodulatory properties is not immunogenic when administered with various adjuvants.
    Avila S; Muñoz-García L; Vázquez-Leyva S; Salinas-Jazmín N; Medina-Rivero E; Pavón L; Mellado-Sánchez G; Chacón-Salinas R; Estrada-Parra S; Vallejo-Castillo L; Pérez-Tapia SM
    J Immunotoxicol; 2017 Dec; 14(1):169-177. PubMed ID: 28707490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®).
    Mellado-Sánchez G; Lázaro-Rodríguez JJ; Avila S; Vallejo-Castillo L; Vázquez-Leyva S; Carballo-Uicab G; Velasco-Velázquez M; Medina-Rivero E; Pavón L; Chacón-Salinas R; Pérez-Tapia SM
    J Immunol Res; 2019; 2019():2754920. PubMed ID: 31223627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Batch-to-batch reproducibility of Transferon™.
    Medina-Rivero E; Merchand-Reyes G; Pavón L; Vázquez-Leyva S; Pérez-Sánchez G; Salinas-Jazmín N; Estrada-Parra S; Velasco-Velázquez M; Pérez-Tapia SM
    J Pharm Biomed Anal; 2014 Jan; 88():289-94. PubMed ID: 24099727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of microneedle-based cutaneous immunization with other conventional routes to assess feasibility of microneedles for allergy immunotherapy.
    Shakya AK; Gill HS
    Vaccine; 2015 Aug; 33(33):4060-4. PubMed ID: 26092307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dialyzable leukocyte extract Transferon
    Hernández-Esquivel MA; Pérez-Torres A; Romero-Romero L; Reyes-Matute A; Loaiza B; Mellado-Sánchez G; Pavón L; Medina-Rivero E; Pestell RG; Pérez-Tapia SM; Velasco-Velázquez MA
    Biomed Pharmacother; 2018 May; 101():938-944. PubMed ID: 29635903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract "Transferon Oral": The Starting Point to Understand Its Mechanism of Action.
    Vallejo-Castillo L; Favari L; Vázquez-Leyva S; Mellado-Sánchez G; Macías-Palacios Z; López-Juárez LE; Valencia-Flores L; Medina-Rivero E; Chacón-Salinas R; Pavón L; Pérez-Tapia SM
    Front Pharmacol; 2020; 11():569039. PubMed ID: 33117165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes murine model as a biological assay to test dialyzable leukocyte extracts activity.
    Salinas-Jazmín N; Estrada-Parra S; Becerril-García MA; Limón-Flores AY; Vázquez-Leyva S; Medina-Rivero E; Pavón L; Velasco-Velázquez MA; Pérez-Tapia SM
    J Immunol Res; 2015; 2015():146305. PubMed ID: 25984538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide.
    van Houten NE; Zwick MB; Menendez A; Scott JK
    Vaccine; 2006 May; 24(19):4188-200. PubMed ID: 16488517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of inoculation route and adjuvant type on the immunizing potency of CVB3 VP1 protein].
    Wen C; Gao ZY; Lan JM; Yan LJ; Chuai X; Li J; Li W; Wang YX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Oct; 27(10):1086-9. PubMed ID: 21968309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airway inflammation and adjuvant effect after repeated airborne exposures to di-(2-ethylhexyl)phthalate and ovalbumin in BALB/c mice.
    Larsen ST; Hansen JS; Hansen EW; Clausen PA; Nielsen GD
    Toxicology; 2007 Jun; 235(1-2):119-29. PubMed ID: 17462807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gantrez AN nanoparticles as an adjuvant for oral immunotherapy with allergens.
    Gómez S; Gamazo C; Roman BS; Ferrer M; Sanz ML; Irache JM
    Vaccine; 2007 Jul; 25(29):5263-71. PubMed ID: 17576025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different adjuvant formulations on the immunogenicity and protective effect of a live Mycoplasma hyopneumoniae vaccine after intramuscular inoculation.
    Xiong Q; Wei Y; Xie H; Feng Z; Gan Y; Wang C; Liu M; Bai F; Xie F; Shao G
    Vaccine; 2014 Jun; 32(27):3445-51. PubMed ID: 24731810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose intraperitoneal Freund's adjuvant: toxicity and immunogenicity in mice using an immunogen targeting amyloid-beta peptide.
    Oscherwitz J; Hankenson FC; Yu F; Cease KB
    Vaccine; 2006 Apr; 24(15):3018-25. PubMed ID: 16307832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological adjuvant effect of Boswellia serrata (BOS 2000) on specific antibody and cellular response to ovalbumin in mice.
    Gupta A; Khajuria A; Singh J; Singh S; Suri KA; Qazi GN
    Int Immunopharmacol; 2011 Aug; 11(8):968-75. PubMed ID: 21371582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CoVaccine HT™ adjuvant is superior to Freund's adjuvants in eliciting antibodies against the endogenous alarmin HMGB1.
    Lakhan N; Stevens NE; Diener KR; Hayball JD
    J Immunol Methods; 2016 Dec; 439():37-43. PubMed ID: 27693642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune responses to ovalbumin in mice following nasal administration.
    Boonyo W; Junginger HE; Waranuch N; Polnok A; Pitaksuteepong T
    J Control Release; 2007 Aug; 121(3):168-75. PubMed ID: 17644205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable Leukocyte Extract Intended for Batch Release.
    Carballo-Uicab G; Linares-Trejo JE; Mellado-Sánchez G; López-Morales CA; Velasco-Velázquez M; Pavón L; Estrada-Parra S; Pérez-Tapia SM; Medina-Rivero E
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31547184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with LPS and Dialyzable Leukocyte Extract (Transferon®).
    Jiménez-Uribe AP; Valencia-Martínez H; Carballo-Uicab G; Vallejo-Castillo L; Medina-Rivero E; Chacón-Salinas R; Pavón L; Velasco-Velázquez MA; Mellado-Sánchez G; Estrada-Parra S; Pérez-Tapia SM
    J Immunol Res; 2019; 2019():2198508. PubMed ID: 31093509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile.
    Schmidt ST; Khadke S; Korsholm KS; Perrie Y; Rades T; Andersen P; Foged C; Christensen D
    J Control Release; 2016 Oct; 239():107-17. PubMed ID: 27574990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting IL-23 by employing a p40 peptide-based vaccine ameliorates murine allergic skin and airway inflammation.
    Guan Q; Ma Y; Aboud L; Weiss CR; Qing G; Warrington RJ; Peng Z
    Clin Exp Allergy; 2012 Sep; 42(9):1397-405. PubMed ID: 22925326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.